Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
Up to 31 subjects diagnosed with oral squamous cell carcinoma received one application of a permeation enhancer 3 treatment applications of a Cisplatin drug-loaded patch to the tumor site at each of the 4 treatment visits. These 4 treatment visits were scheduled to occur during the 3 weeks prior to the standard of care tumor resection. Funding Source: FDA OOPD
Epistemonikos ID: 4aa75a7deb49fcdcd8f8317bab5fd810a8dd8e92
First added on: May 21, 2024